The report highlights Incyte's progress in environmental, social, and governance (ESG) efforts, reflecting the company's commitment to responsible research and development of medicines to improve patient lives. It includes information aligned with the Sustainability Accounting Standards Board (SASB) standards, the Task Force on Climate-Related Financial Disclosures (TCFD) recommendations, and the United Nations Sustainable Development Goals (SDGs). Key achievements include: achieving operational carbon neutrality for 2019-2021, obtaining Green Globes Certification for Building 1815, doubling contributions to the Cancer Care Assistance Fund, and increasing the diversity of their U.S. Board of Directors to 33% women.
Issuing Company Incyte Corporation
Report Type Sustainability Report
Report Language EN
Report Filesize 2.84 MB
No. of Pages 47 pages
Reporting periodJanuary 1, 2022-December 31, 2022
Report EditionUnknown
Assurance Provider Unknown
Reporting Standards SASB; TCFD; UNSDGs
Materiality Assessmenttrue